Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bluteau

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Gastroenterologie Clinique Et Biologique|March 26, 2002
[Genetic alterations in hepatocellular carcinomas: associations with clinical parameters]O Bluteau, P Laurent-Puig, J Zucman-Rossi
Biotechniques|January 13, 2000
PCR-based genotyping can generate artifacts in LOH analysesO Bluteau, P Legoix, P Laurent-Puig, et al.
Oncogene|August 6, 1999
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosityP Legoix, O Bluteau, J Bayer, et al.
Gastroenterology|May 29, 2001
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesisP Laurent-Puig, P Legoix, O Bluteau, et al.
Journal of Thrombosis and Haemostasis : JTH|September 30, 2016
The cell division control protein 42-Src family kinase-neural Wiskott-Aldrich syndrome protein pathway regulates human proplatelet formationA Palazzo, O Bluteau, K Messaoudi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 21, 2013
Developmental changes in human megakaryopoiesisO Bluteau, T Langlois, P Rivera-Munoz, et al.
Gastroenterologie Clinique Et Biologique|January 5, 2000
[Semi-automated quantitative method for detecting the loss of heterozygosity at the long arm of chromosome 4 in hepatocellular carcinoma]O Bluteau, P Legoix, J Bayer, et al.
Cell Death & Disease|July 27, 2012
Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitroH Moniz, M Gastou, T Leblanc, et al.
Cell Death & Disease|July 27, 2013
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanismsA Ali, O Bluteau, K Messaoudi, et al.
Leukemia|September 13, 2014
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolutionX Cabagnols, J P Defour, V Ugo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Gastroenterologie Clinique Et Biologique|March 26, 2002
[Genetic alterations in hepatocellular carcinomas: associations with clinical parameters]O Bluteau, P Laurent-Puig, J Zucman-Rossi
Biotechniques|January 13, 2000
PCR-based genotyping can generate artifacts in LOH analysesO Bluteau, P Legoix, P Laurent-Puig, et al.
Oncogene|August 6, 1999
Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosityP Legoix, O Bluteau, J Bayer, et al.
Gastroenterology|May 29, 2001
Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesisP Laurent-Puig, P Legoix, O Bluteau, et al.
Journal of Thrombosis and Haemostasis : JTH|September 30, 2016
The cell division control protein 42-Src family kinase-neural Wiskott-Aldrich syndrome protein pathway regulates human proplatelet formationA Palazzo, O Bluteau, K Messaoudi, et al.
Journal of Thrombosis and Haemostasis : JTH|June 21, 2013
Developmental changes in human megakaryopoiesisO Bluteau, T Langlois, P Rivera-Munoz, et al.
Gastroenterologie Clinique Et Biologique|January 5, 2000
[Semi-automated quantitative method for detecting the loss of heterozygosity at the long arm of chromosome 4 in hepatocellular carcinoma]O Bluteau, P Legoix, J Bayer, et al.
Cell Death & Disease|July 27, 2012
Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitroH Moniz, M Gastou, T Leblanc, et al.
Cell Death & Disease|July 27, 2013
Thrombocytopenia induced by the histone deacetylase inhibitor abexinostat involves p53-dependent and -independent mechanismsA Ali, O Bluteau, K Messaoudi, et al.
Leukemia|September 13, 2014
Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolutionX Cabagnols, J P Defour, V Ugo, et al.
Pageof 1